Influenza Vaccines

A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD

Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines

Vaccination Nudges From Pharmacists

Characterizing the Human Airway Immune Response to FluMist Vaccination

Vaccine Chatbot for Improving Influenza Vaccination Uptake

Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children

Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents

Influenza Vaccine Uptake Among Healthcare Workers

Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23

Financing Strategies of Influenza Vaccination in China

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis

Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children

Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults

Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population

Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)

A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk

Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years

Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado